Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.65 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.65 |
| ▸ | GLA | P06280 | 2/20 | 0.65 |
| ▸ | GAA | P10253 | 2/20 | 0.65 |
| ▸ | HTT | P42858 | 2/20 | 0.65 |
| ▸ | DAO | P14920 | 1/20 | 0.52 |
| ▸ | FEN1 | P39748 | 1/20 | 0.51 |
| ▸ | LMNA | P02545 | 2/20 | 0.49 |
| ▸ | HPGD | P15428 | 2/20 | 0.49 |
| ▸ | MEN1 | O00255 | 5/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.47 |
| ▸ | PARP1 | P09874 | 1/20 | 0.46 |
| ▸ | KIF11 | P52732 | 1/20 | 0.46 |
| ▸ | ATM | Q13315 | 1/20 | 0.45 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.45 |
| ▸ | CDC25A | P30304 | 1/20 | 0.44 |
| ▸ | CDC25C | P30307 | 1/20 | 0.44 |
| ▸ | CCNE2 | O96020 | 1/20 | 0.44 |
| ▸ | CDK4 | P11802 | 1/20 | 0.44 |
| ▸ | CCND1 | P24385 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14668858 | 0.88 | KDM4E (0.76) | KDM4EALDH1A1GLAGAAHTT | |
| SCHEMBL9708991 | 0.86 | GAA (0.80) | KDM4EALDH1A1GLAGAAHTT | |
| SCHEMBL21327343 | 0.84 | KIF11 (0.66) | KDM4EALDH1A1GLAGAAHTT | |
| SCHEMBL14598932 | 0.83 | GAA (0.93) | KDM4EALDH1A1GLAGAAHTT | |
| SCHEMBL1517851 | 0.82 | KIF11 (0.61) | KDM4EALDH1A1GLAGAAHTT | |
| SCHEMBL29507671 | 0.82 | KIF11 (0.61) | KDM4EALDH1A1GLAGAAHTT | |
| SCHEMBL5444428 | 0.79 | ALDH1A1 (1.00) | KDM4EALDH1A1GLAGAAHTT | |
| SCHEMBL14668859 | 0.78 | KIF11 (0.68) | KDM4EALDH1A1GLAGAAHTT | |
| SCHEMBL12075227 | 0.77 | KDM4E (0.57) | KDM4EALDH1A1GLAGAAHTT | |
| SCHEMBL276017 | 0.76 | ALDH1A1 (0.65) | KDM4EALDH1A1GLAGAAHTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3561876-B1 | DISPLAY | NOVALED GMBH (DE) | 2022-02-16 | — | — | EP | disclosed |
| EP-3561876-A1 | DISPLAY | Novaled GmbH (DE) | 2019-10-30 | — | — | EP | disclosed |
| US-10396293-B2 | Electronic or optoelectronic device comprising an anchored thin molecular layer, process for its preparation and compound used therein | NOVALED GMBH (DE) | 2019-08-27 | — | — | US | disclosed |
| EP-2786435-B1 | Compounds | NOVALED GMBH (DE) | 2019-07-17 | — | — | EP | disclosed |
| EP-2840622-B1 | Electronic or optoelectronic device comprising an anchored thin molecular layer, process for its preparation and compound used therein | NOVALED GMBH (DE) | 2019-02-13 | — | — | EP | disclosed |
| US-9722183-B2 | Display | NOVALED GMBH (DE) | 2017-08-01 | — | — | US | disclosed |
| US-20160211461-A1 | Electronic or Optoelectronic Device Comprising an Anchored Thin Molecular Layer, Process for its Preparation and Compound Used Therein | NOVALED GMBH (DE) | 2016-07-21 | — | — | US | disclosed |
| EP-2840622-A1 | Electronic or optoelectronic device comprising an anchored thin molecular layer, process for its preparation and compound used therein | Novaled GmbH (DE) | 2015-02-25 | — | — | EP | disclosed |
| US-20140332790-A1 | Display | NOVALED GMBH (DE) | 2014-11-13 | — | — | US | disclosed |
| EP-2786435-A1 | DISPLAY | Novaled GmbH (DE) | 2014-10-08 | — | — | EP | disclosed |
| US-8637858-B2 | Tandem white OLED | NOVALED AG (DE) | 2014-01-28 | — | — | US | disclosed |
| WO-2013079217-A1 | DISPLAY | NOVALED AG (DE) | 2013-06-06 | — | — | WO | disclosed |
| US-20120074392-A1 | Tandem White OLED | NOVALED AG (DE) | 2012-03-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160211461-A1 | Electronic or Optoelectronic Device Comprising an Anchored Thin Molecular Layer, Process for its Preparation and Compound Used Therein | EPCAM, OR10J3, OR51E2 | KDM4E 215/4885ALDH1A1 1046/4885GLA 4109/4885 |
| US-10396293-B2 | Electronic or optoelectronic device comprising an anchored thin molecular layer, process for its preparation and compound used therein | EPCAM, OR10J3, OR51E2 | KDM4E 215/4885ALDH1A1 1046/4885GLA 4109/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.